India

The difficult momentum of Indian pharma sector
The difficult momentum of Indian pharma sector
GoinPharma
India
generics
Sun Pharma
Cipla
Dr Reddy's
Lupin
Flag link:
Merck KGaA injects $47M into Asian manufacturing efforts
Merck KGaA injects $47M into Asian manufacturing efforts
Biopharma Dive
Merck KGaA
drug manufacturing
Asia
India
South Korea
Flag link:
Indian, Chinese drugmakers eye Sanofi's European generics unit for $2B deal: report
Indian, Chinese drugmakers eye Sanofi's European generics unit for $2B deal: report
Fierce Pharma
Sanofi
Europe
generics
China
India
Flag link:
Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy
Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy
Fierce Pharma
Biocon
Mylan Labs
FDA
Herceptin
drug manufacturing
biologics
India
Flag link:
Indian pharma sector keeps consolidating: Torrent acquires Unichem Laboratories
Indian pharma sector keeps consolidating: Torrent acquires Unichem Laboratories
GoinPharma
India
Torrent Pharmaceuticals
Unichem Laboratories
M&A
Flag link:
Medtech Industry Frowns on India Price Caps
Medtech Industry Frowns on India Price Caps
Medical Device and Diagnostic Industry
devices
India
Flag link:
China’s big pharma targets India
China’s big pharma targets India
GoinPharma
China
India
Fosun Pharmaceutical
Symbiotec
Flag link:
Indian gov’t mulls price cap on ‘essential’ medical devices
Indian gov’t mulls price cap on ‘essential’ medical devices
Mass Device
India
devices
Flag link:
OrbiMed lines up $551M gamble on China, India biotech sectors
OrbiMed lines up $551M gamble on China, India biotech sectors
Endpoints
OrbiMed
China
India
biotech
venture capital
Flag link:
With U.S. Generic Drug Market in Chaos, Indian Upstarts Rise
With U.S. Generic Drug Market in Chaos, Indian Upstarts Rise
Bloomberg
generics
India
Flag link:
Pfizer Wins Indian Patent on Prevnar 13 Vaccine
Pfizer Wins Indian Patent on Prevnar 13 Vaccine
RAPS.org
Pfizer
India
Prevnar 13
vaccine
patents
Flag link:
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
GoInPharma
Intas
India
M&A
Teva Pharmaceutical
Europe
Women's Health
oncology
pain management
Flag link:
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
Mass Device
FDA
India
clinical trials
Flag link:
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
FDA Voice
FDA
India
clinical trials
Flag link:
Indian drugmaker stages worker strike to avoid FDA inspection
Indian drugmaker stages worker strike to avoid FDA inspection
BioPharma Dive
India
FDA
inspection
warning letter
Flag link:
The Billionaire And The Drug Price-Fixing Scandal
The Billionaire And The Drug Price-Fixing Scandal
Forbes
price fixing
India
Heritage Pharmaceuticals
Emcure
Flag link:
FDA jumps on another Mylan plant in India, slapping it with a warning letter
FDA jumps on another Mylan plant in India, slapping it with a warning letter
Fierce Pharma
FDA
drug manufacturing
India
Mylan Labs
Flag link:
India Authorized Agent Role Changes under New Medical Device Rules
India Authorized Agent Role Changes under New Medical Device Rules
Emergo
India
devices
Flag link:
As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters
As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters
Fierce Pharma
Bayer
intellectual property
India
exporting
Xarelto
Nexavar
Flag link:
India wants to sell low-cost drugs in Trump’s America, but quality questions persist
India wants to sell low-cost drugs in Trump’s America, but quality questions persist
Fierce Pharma
India
drug manufacturing
Flag link:

Pages